News
Eli Lilly (NYSE: LLY) was an unstoppable bet in the past few years, but LLY stock finally started plateauing in the latter ...
20d
Irish Examiner on MSNEli Lilly’s weight-loss drug revenues miss expectations due to lower pricesOn an adjusted basis, Lilly earned $3.34 per share for the quarter, compared with analysts’ estimates of $3.02 per share ...
5don MSN
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...
US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...
The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard Jorgensen is stepping down, as its obesity injection Wegovy loses ground to Eli ... to lower drug prices and ...
INDIANAPOLIS — Eli Lilly's stock wobbled ... able to switch to Wegovy if the Lilly drug is excluded from their coverage, Whitrap said. CVS Health also said Thursday that it will start selling Wegovy ...
Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that longtime CEO Lars Fruergaard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results